Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

RARE

Live52w low +32.3%

Loading latest news…

Log in Get Started

☁️ News word cloud

Top words across the last 50 articles for this ticker.

ultragenyxclassactioninvestorspharmaceuticallawsuitsecuritiesdeadlineaprilphaseagainst2026leadfiled2025decembersetrusumabplaintiffstatementsosteogenesis

Loading latest news…

52w low +32.3%

☁️ News word cloud

Top words across the last 50 articles for this ticker.

ultragenyxclassactioninvestorspharmaceuticallawsuitsecuritiesdeadlineaprilphaseagainst2026leadfiled2025decembersetrusumabplaintiffstatementsosteogenesis